XML 65 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-based compensation and Shareholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements
A summary of the status of the Company’s stock-settled awards, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:
 Year ended December 31, 2023
 Stock appreciation rightsStock units
AwardsWeighted
average
exercise
price
Weighted
average
remaining
contractual life
AwardsWeighted
average
remaining
contractual life
Outstanding at beginning of year5,390 $66.00  3,072  
Granted—  1,383  
Added by performance factor66 
Exercised/Vested(1,872)$63.75  (1,067) 
Canceled(47)$52.41  (231) 
Outstanding at end of period3,471 $67.40 0.913,223 2.21
Exercisable at end of period3,076 $63.42 0.75— — 
Weighted-average fair value of grants:
2023  $77.61  
2022$35.13   $107.60  
2021$32.15   $109.50  
Summary of Range of Exercise Prices
 Awards OutstandingWeighted average exercise priceAwards exercisableWeighted average exercise price
Range of SSARs base prices
$50.01–$60.00945 $52.41 945 $52.41 
$60.01–$70.002,000 $67.80 2,000 $67.80 
$70.01–$80.00264 $75.95 131 $75.95 
$100.01–$110.00132 $108.93 
$110.01–$120.00130 $110.63 
Total3,471 $67.40 3,076 $63.42 
Summary of Weighted Average Valuation Inputs
A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:
 
 20222021
Expected term4.54.5
Expected volatility34.3 %34.3 %
Expected dividend yield— %— %
Risk-free interest rate2.1 %0.7 %